Trivant Custom Portfolio Group, LLC Mannkind Corp Transaction History
Trivant Custom Portfolio Group, LLC
- $157 Billion
- Q1 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 150 shares of MNKD stock, worth $769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$769
Previous $546,000
24.54%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
210Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$77.7 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$61.3 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$51.7 Million4.85% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$46.2 Million0.49% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.32B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...